Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | MLYCD | O95822 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 2/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4432399 | 0.95 | PTPN5 (0.34) | TSHRCA1CA2CA5ACA9 | |
| SCHEMBL20380670 | 0.89 | PTGS2 (0.34) | GPR3 | |
| SCHEMBL12829123 | 0.89 | TSHR (0.34) | TSHRCA1CA2CA5ACA9 | |
| SCHEMBL18887861 | 0.87 | HTR2A (0.33) | CA1CA2CA5ACA9HTR2A | |
| SCHEMBL18735552 | 0.87 | CYP11B1 (0.32) | KIF11 | |
| SCHEMBL12829125 | 0.86 | GPR3 (0.36) | TSHRCA1CA2CA5ACA9 | |
| SCHEMBL16866174 | 0.86 | AKR1C3 (0.37) | KIF11 | |
| SCHEMBL14945438 | 0.86 | GPR3 (0.35) | TSHRCA1CA2CA5ACA9 | |
| SCHEMBL2741564 | 0.85 | AKR1C3 (0.39) | GPR3KIF11 | |
| SCHEMBL20003578 | 0.85 | PTPN5 (0.31) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043781-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-12043781-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-20230383186-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-20230383186-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-11739267-B2 | LC medium | MERCK PATENT GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| US-11739267-B2 | LC medium | MERCK PATENT GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | MERCK PATENT GMBH (DE) | 2023-08-08 | — | — | US | disclosed |
| US-11685863-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | MERCK PATENT GMBH (DE) | 2023-06-27 | — | — | US | disclosed |
| US-20230007940-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCKP PATENT GMBH (DE) | 2023-01-12 | — | — | US | disclosed |
| US-20210348056-A1 | Polymerisable Compounds and the Use thereof in Liquid-Crystal Displays | MERCK PATENT GMBH (DE) | 2021-11-11 | — | — | US | disclosed |
| US-20070237907-A1 | PHOTOSTABLE LIQUID-CRYSTALLINE MEDIUM | MANABE ATSUTAKA | 2007-10-11 | — | — | US | disclosed |
| US-20070176146-A1 | Liquid-crystalline medium and liquid-crystal display | MERCK PATENT GMBH (DE) | 2007-08-02 | — | — | US | disclosed |
| US-20070170395-A1 | Liquid crystal medium | MERCK PATENT GESELLSCHAFT | 2007-07-26 | — | — | US | disclosed |
| US-7211302-B2 | Photostable liquid crystalline medium | MERCK PATENT GMBH (DE) | 2007-05-01 | — | — | US | disclosed |
| US-20070034830-A1 | Mixture of polar compounds containing cyclohexane and benzene rings some of which are vinylene-linked, especially containing fluoroalkoxy groups; for electrooptical twisted nematic monitor applications. | MERCK PATENT GMBH (DE) | 2007-02-15 | — | — | US | disclosed |
| US-7175891-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2007-02-13 | — | — | US | disclosed |
| US-20070001149-A1 | Liquid-crystal medium containing monofluoroterphenyl compounds | MERCK PATENT GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| EP-0786445-B1 | DIFLUOROXYMETHANE DERIVATIVE AND LIQUID CRYSTAL COMPOSITION | CHISSO CORP (JP) | 2002-07-17 | — | — | EP | disclosed |
| US-5858270-A | Difluorooxymethane derivative and liquid crystal composition | CHISSO CORPORATION (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0786445-A1 | DIFLUOROXYMETHANE DERIVATIVE AND LIQUID CRYSTAL COMPOSITION | CHISSO CORPORATION (JP) | 1997-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | VCL, ILK, LCP1 | TSHR 4856/4885CA1 1516/4885CA2 2251/4885 |
| US-11685863-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | LPXN, VCL, LCP1 | TSHR 4868/4885CA1 626/4885CA2 1613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.